Anti-HIV chemotherapy: Current state of the art

Medicinal Chemistry Research

Volumn 13, Issue 6-7, 2004, Pages 439-478

  De Clercq, Erik ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1 [5 (4 FLUOROBENZYL) 2 FURYL] 3 (1,2,4 TRIAZOL 3 YL) 1,3 PROPANEDIONE; 1 ACETYL N [3 [4 (4 CARBAMOYLBENZYL) 1 PIPERIDINYL]PROPYL] N (3 CHLORO 4 METHYLPHENYL) 4 PIPERIDINECARBOXAMIDE; 1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); 3 DEAZANEPLANOCIN A; 4 [(4 BROMOPHENYL)(ETHOXYIMINO)METHYL] 1' [(2,4 DIMETHYL 3 PYRIDINYL)CARBONYL] 4' METHYL 1,4' BIPIPERIDINE; 4 [1 (4 FLUOROBENZYL) 2 PYRROLYL] 2,4 DIOXOBUTYRIC ACID; 4 [1 [(2,4 DIMETHYL 3 PYRIDINYL)CARBONYL] 4 METHYL 4 PIPERIDINYL] 2 METHYL 1 [1 [4 (TRIFLUOOROMETHYL)PHENYL]ETHYL]PIPERAZINE; 4 BENZOYL 1 [(4 METHOXY 1H PYRROLO[2,3 B]PYRIDIN 3 YL)OXOACETYL] 2 METHYLPIPERAZINE; 6 AMINOQUINOLONE; 6 CHLORO 4 (2 CYCLOPROPYLVINYL) 3,4 DIHYDRO 4 TRIFLUOROMETHYL 2(1H) QUINAZOLINONE; 8 HYDROXY[1,6]NAPHTHYRIDINE; ABACAVIR; ADEFOVIR DIPIVOXIL; AMD 070; AMDOXOVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; CAPRAVIRINE; CD4 ANTIGEN; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CICHORIC ACID; COMPOUND 167; CYANOVIRIN N; CYCLOTRIAZADISULFONAMIDE DERIVATIVE; DAPIVIRINE; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; ELVUCITABINE; EMTRICITABINE; ENFUVIRTIDE; ETRAVIRINE; GLYCOPEPTIDE; GLYCOPROTEIN GP 120; INDINAVIR; INTEGRASE INHIBITOR; JPL 32; K 37; KRH 1636; L 708906; LAMIVUDINE; LOPINAVIR; MRK 1; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; N AMINOIMIDAZOLE DERIVATIVE; NELFINAVIR; NEVIRAPINE; PKF 050638; PLANT LECTIN; PROTEINASE INHIBITOR; PYRANODIPYRIMIDINE DERIVATIVE; PYRIDINE 1 OXIDE; RITONAVIR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; SK 602; STAVUDINE; TEICOPLANIN; TENOFOVIR DISOPROXIL; TIPRANAVIR; TMC 126; UIC 94003; UNCLASSIFIED DRUG; V 165; ZALCITABINE; ZIDOVUDINE;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; SEXUAL TRANSMISSION; SIMIAN IMMUNODEFICIENCY VIRUS; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 20344371721     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-004-0047-1     Document Type: Conference Paper

References (131)

1. De Clercq, E. Frontiers in Medicinal Chemistry 2004, 1, 543-579.
2. Vermeire, K.; Zhang, Y.; Princen, K.; Hatse, S.; Samala, M.F.; Dey, K.; Choi, H.-J.; Ahn, Y.; Sodoma, A.; Snoeck, R.; Andrei, G.; De Clercq, E.; Bell, T.W.; Schols, D. Virology 2002, 302, 342-353.
3. Vermeire, K.; Bell, T.W.; Choi, H.-J.; Jin, Q.; Samala, M.F.; Sodoma, A.; De Clercq, E.; Schols, D. Mol. Pharmacol. 2003, 63, 203-210.
4. Vermeire, K.; Bell, T.W.; Dey, K.; Hatse, S.; Princen, K.; De Clercq, E.; Schols, D. AIDS 2004, in press.
5. Baizarini, J.; Hatse, S.; Vermeire, K.; Princen, K.; De Clercq, E.; Egberink, H.; Van Den Mooter, G.; Peumans, W.; Van Damme, E.; Schols, D. Antimicrob. Agents Chemother. 2004, in press.
6. Balzarini, J.; Van Laethem, K.; Hatse, S.; Vermeire, K.; De Clercq, E.; Peumans, W.; Van Damme, E.; Vandamme, A.-M.; Böhlmstedt, A.; Schols, D. J. Virol. 2004, 78, 10617-10627.
7. Boyd, M.R.; Gustafson, K.R.; McMahon, J.B.; Shoemaker, R.H.; O'Keefe, B.R.; Mori, T.; Gulakowski, R.J.; Wu, L.; Rivera, M.I.; Laurencot, C.M.; Currens, M.J.; Cardellina II, J.H.; Buckheit Jr., R.W.; Nara, P.L.; Pannell, L.K.; Sowder II, R.C.; Henderson, L.E. Antimicrob. Agents Chemother. 1997, 41, 1521-1530.
8. Mori, T.; Boyd, M.R. Antimicrob. Agents Chemother. 2001, 45, 664-672.
9. Botos, I.; Wlodawer, A. Cell. Mol. Life Sci. 2003, 60, 277-287.
10. Balzarini, J.; Pannecouque, C.; De Clercq, E.; Pavlov, A.Y.; Printsevskaya, S.S.; Miroshnikova, O.V.; Reznikova, M.I.; Preobrazhenskaya, M.N. J. Med. Chem. 2003, 46, 2755-2764.
11. Wang, T.; Zhang, Z.; Wallace, O.B.; Deshpande, M.; Fang, H.; Yang, Z.; Zadjura, L.M.; Tweedie, D.L.; Huang, S.; Zhao, F.; Ranadive, S.; Robinson, B.S.; Gong, Y.-F.; Ricarrdi, K.; Spicer, T.P.; Deminie, C.; Rose, R.; Wang, H.-G.H.; Blair, W.S.; Shi, P.-Y.; Lin, P.-f.; Colonno, R.J.; Meanwell, N.A. J. Med. Chem. 2003, 46, 4236-4239.
12. Guo, Q.; Ho, H.-T.; Dicker, I.; Fan, L.; Zhou, N.; Friborg, J.; Wang, T.; McAuliffe, B.V.; Wang, H.-g.H.; Rose, R.E.; Fang, H.; Scarnati, H.T.; Langley, D.R.; Meanwell, N.A.; Abraham, R.; Colonno, R.J.; Lin, P.-f. J. Virol. 2003, 77, 10528-10536.
13. Lin, P.-F.; Blair, W.; Wang, T.; Spicer, T.; Guo, Q.; Zhou, N.; Gong, Y.-F.; Wang, H.-G.H.; Rose, R.; Yamanaka, G.; Robinson, B.; Li, C.-B.; Fridell, R.; Deminie, C.; Demers, G.; Yang, Z.; Zadjura, L.; Meanwell, N.; Colonno, R. Proc. Natl. Acad. Sci. USA 2003, 100, 11013-11018.
14. De Clercq, E. Nature Rev. Drug Discovery 2003, 2, 581-587.
15. Hendrix, C.W.; Flexner, C.; MacFarland, R.T.; Giandomenico, C.; Fuchs, E.J.; Redpath, E.; Bridger, G.; Henson, G.W. Antimicrob. Agents Chemother. 2000, 44, 1667-1673.
16. Schols, D.; Claes, S.; De Clercq, E.; Hendrix, C.; Bridger, G.; Calandra, G.; Henson, G.W.; Fransen, S.; Huang, W.; Whitcomb, J.M.; Petropoulos, C.J.; AMD-3100 HIV Study Group. 9th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, USA, 24-28 February 2002. Abstracts, p 53, no 2.
17. th Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA, 10-14 February 2003. Abstracts, no. 563.
18. Schols, D.; Claes, S.; Hatse, S.; Princen, K.; Vermeire, K.; De Clercq, E.; Skerlj, R.; Bridger, G.; Calandra, G. 16th International Conference on Antiviral Research, Savannah, Georgia, USA, 27 April-1 May 2003. Antiviral Res. 2003, 57, A39, no. 2.
19. Ichiyama, K.; Yokoyama-Kumakura, S.; Tanaka, Y.; Tanaka, R.; Hirose, K.; Bannai, K.; Edamatsu, T.; Yanaka, M.; Niitani, Y.; Miyano-Kurosaki, N.; Takaku, H.; Koyanagi, Y.; Yamamoto, N. Proc. Natl. Acad. Sci. USA 2003, 100, 4185-4190.
20. Baba, M.; Nishimura, O.; Kanzaki, N.; Okamoto, M.; Sawada, H.; Iizawa, Y.; Shiraishi, M.; Aramaki, Y.; Okonogi, K.; Ogawa, Y.; Meguro, K.; Fujino, M. Proc. Natl. Acad. Sci. USA 1999, 96, 5698-5703.
21. Dragic, T.; Trkola, A.; Thompson, D.A.; Cormier, E.G.; Kajumo, F.A.; Maxwell, E.; Lin, S.W.; Ying, W.; Smith, S.O.; Sakmar, T.P.; Moore, J.P. Proc. Natl. Acad. Sci. USA 2000, 97, 5639-5644.
22. th Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA, 10-14 February 2003. Abstracts, no. 11.
23. Strizki, J.M.; Xu, S.; Wagner, N.E.; Wojcik, L.; Liu, J.; Hou, Y.; Endres, M.; Palani, A.; Shapiro, S.; Clader, J.W.; Greenlee, W.J.; Tagat, J.R.; McCombie, S.; Cox, K.; Fawzi, A.B.; Chou, C.-C.; Pugliese-Sivo, C.; Davies, L.; Moreno, M.E.; Ho, D.D.; Trkola, A.; Stoddart, C.A.; Moore, J.P.; Reyes, G.R.; Baroudy, B.M. Proc. Natl. Acad. Sci. USA 2001, 98, 12718-12723.
24. Reynes, J.; Rouzier, R.; Kanouni, T.; Baillat, V.; Baroudy, B.; Keung, A.; Hogan, C.; Markowitz, M.; Laughlin, M. 9th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, USA, 24-28 February 2002. Abstracts, p 53, no 1.
25. Palani, A.; Shapiro, S.; Clader, J.W.; Greenlee, W.J.; Vice, S.; McCombie, S.; Cox, K.; Strizki, J.; Baroudy, B.M. Bioorg. Med. Chem. Lett. 2003, 13, 709-712.
26. Tsamis, F.; Gravilov, S.; Kajumo, F.; Seibert, C.; Kuhmann, S.; Ketas, T.; Trkola, A.; Palani, A.; Clader, J.W.; Tagat, J.R.; McCombie, S.; Baroudy, B.; Moore, J.P.; Sakmar, T.P.; Dragic, T. J. Virol. 2003, 77, 5201-5208.
27. Maeda, K.; Yoshimura, K.; Shibayama, S.; Habashita, H.; Tada, H.; Sagawa, K.; Miyakawa, T.; Aoki, M.; Fukushima, D.; Mitsuya, H. J. Biol Chem. 2001, 276, 35194-35200.
28. Maeda, K.; Nakata, H.; Miyakawa, T.; Ogata, H.; Koh, Y.; Takaoka, Y.; Shibayama, S.; Moravek, J.; Koyanagi, Y.; Mitsuya, H. HIV DART 2002, Frontiers in Drug Development for Antiretroviral Therapies, Naples, Florida, USA, 15-19 December 2002. Antiviral Res. 2002, Abstracts, no 014.
29. Hale, J.J.; Budhu, R.J.; Holson, E.B.; Finke, P.E.; Gates, B.; Mills, S.G.; MacCoss, M.; Gould, S.L.; DeMartino, J.A.; Springer, M.S.; Siciliano, S.; Malkowitz, L.; Schleif, W.A.; Hazuda, D.; Miller, M.; Kessler, J.; Danzeisen, R.; Holmes, K.; Lineberger, J.; Carella, A.; Carver, G.; Emini, E. Bioorg. Med. Chem. Lett. 2001, 11, 2741-2745.
30. Hale, J.J.; Budhu, R.J.; Mills, S.G.; MacCoss, M.; Gould, S.L.; DeMartino, J.A.; Springer, M.S.; Siciliano, S.J.; Malkowitz, L.; Schleif, W.A.; Hazuda, D.; Miller, M.; Kessler, J.; Danzeisen, R.; Holmes, K.; Lineberger, J.; Carella, A.; Carver, G.; Emini, E.A. Bioorg. Med. Chem. Lett. 2002, 12, 2997-3000.
31. Lynch, C.L.; Gentry, A.L.; Hale, J.J.; Mills, S.G.; MacCoss, M.; Malkowitz, L., Springer, M.S.; Gould, S.L.; DeMartino, J.A.; Siciliano, S.J.; Cascieri, M.A.; Doss, G.; Carella, A.; Carver, G.; Holmes, K.; Schleif, W.A.; Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.; Emini, E.A. CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidines. Bioorg. Med. Chem. Lett. 2002, 12, 677-679.
32. Lynch, C.L.; Hale, J.J.; Budhu, R.J.; Gentry, A.L.; Mills, S.G.; Chapman, K.T.; MacCoss, M.; Malkowitz, L.; Springer, M.S.; Gould, S.L.; DeMartino, J.A.; Siciliano, S.J.; Cascieri, M.A.; Carella, A.; Carver, G.; Holmes, K.; Schleif, W.A.; Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.; Emini, E.A. Bioorg. Med. Chem. Lett. 2002, 12, 3001-3004.
33. Willoughby, C.A.; Rosauer, K.G.; Hale, J.J.; Budhu, R.J.; Mills, S.G.; Chapman, K.T.; MacCoss, M.; Malkowitz, L.; Springer, M.S.; Gould, S.L.; DeMartino, J.A.; Siciliano, S.J.; Cascieri, M.A.; Carella, A.; Carver, G.; Holmes, K.; Schleif, W.A.; Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.; Emini, E.A. Bioorg. Med. Chem. Lett. 2003, 13, 427-431.
34. Castonguay, L.A.; Weng, Y.; Adolfsen, W.; Di Salvo, J.; Kilburn, R.; Caldwell, C.G.; Daugherty, B.L.; Finke, P.E.; Haie, J.J.; Lynch, C.L.; Mills, S.G.; MacCoss, M.; Springer, M.S.; DeMartino, J.A. Biochemistry 2003, 42, 1544-1550.
35. Veazey, R.S.; Klasse, P.J.; Ketas, T.J.; Reeves, J.D.; Piatak Jr., M.; Kunstman, K.; Kuhmann, S.E.; Marx, P.A.; Lifson, J.D.; Dufour, J.; Mefford, M.; Pandrea, I.; Wolinsky, S.M.; Doms, R.W.; DeMartino, J.A. Siciliano, S.J.; Lyons, K.; Springer, M.S.; Moore; J.P. J. Exp. Med. 2003, 198, 1551-1562.
36. Kilby, J.M.; Hopkins, S.; Venetta, S.M.; DiMassimo, B.; Cloud, G.A.; Lee, J.Y.; Alldredge, L.; Hunter, E.; Lambert, D.; Bolognesi, D.; Matthews, T.; Johnson, M.R.; Nowak, M.A.; Shaw, G.M.; Saag, M.S., Nat. Med. 1998, 4, 1302-1307.
37. Lalezari, J.P.; Henry, K.; O'Hearn, M.; Montaner, J.S.G.; Piliero, P.J.; Trottier, B.; Walmsley, S.; Cohen, C.; Kuritzkes, D.R.; Eron Jr., J.J., Chung, J.; DeMasi, R.; Donatacci, L.; Drobnes, C.; Delehanty, J.; Salgo, M. N. Engl. J. Med. 2003, 348, 2175-2185.
38. Lazzarin, A.; Clotet, B.; Cooper, D.; Reynes, J.; Arastéh, K.; Nelson, M.; Katlama, C.; Stellbrink, H.-J.; Delfraissy, J.-F.; Lange, J.; Huson, L.; DeMasi, R.; Wat, C.; Delehanty, J.; Drobnes, C.; Salgo, M. N. Engl. J. Med. 2003, 348, 2186-2195.
39. nd IAS Conference on HIV and Pathogenesis, Paris, France, 14-17 July 2003. Abstracts.
40. nd IAS Conference on HIV and Pathogenesis, Paris, France, 14-17 July 2003. Abstracts.
41. Bray, B.L. Nature Rev. Drug Discovery 2003, 2, 587-593.
42. Rimsky, L.T.; Shugars, D.C.; Matthews, T.J. J. Virol. 1998, 72, 986-993.
43. Wei, X.; Decker, J.M.; Liu, H.; Zhang, Z.; Arani, R.B.; Kilby, J.M.; Saag, M.S.; Wu, X.; Shaw, G.M.; Kappes, J.C., Antimicrob. Agents Chemother. 2002, 46, 1896-1905.
44. th Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA, 10-14 February 2003. Abstracts, no. 615.
45. Ketas, T.J.; Klasse, P.J., Spenlehauer, C.; Nesin, M.; Frank, I.; Pope, M.; Strizki, J.M.; Reyes, G.R.; Baroudy, B.M.; Moore, J.P. AIDS Res. Hum. Retrovir. 2003, 19, 177-186.
46. Rousseau, F.S.; Kahn, J.O.; Thompson, M.; Mildvan, D.; Shepp, D.; Sommadossi, J.P.; Delehanty, J.; Simpson, J.N.; Wang, L.H.; Quinn, J.B.; Wakeford, C.; van der Horst, C. J. Antimicrob. Chemother. 2001, 48, 507-513.
47. Molina, J.M.; Perchai, F.; Rancinan, C.; Raffi, F.; Rozenbaum, W.; Sereni, D.; Morlat, P.; Journot, V.; Decazes, J.M.; Chene, G. J. Infect. Dis. 2000, 182, 599-602.
48. nd IAS Conference on HIV and Pathogenesis, Paris, France, 14-17 July 2003. Abstracts.
49. Richman, D.D. Antiviral Ther. 2001, 6, 83-88.
50. Hazen, R.; Lanier, E.R. J. Acquir. Immune Defic. Syndr. 2003, 32, 255-258.
51. Stoddart, C.A.; Moreno, M.E.; Linquist-Stepps, V.D.; Bare, C.; Bogan, M.R.; Gobbi, A.; Buckheit Jr., R.W.; Bedard, J.; Rando, R.F.; McCune, J.M. Antimicrob. Agents Chemother. 2000, 44, 783-786.
52. Otto, M.J.; Arastèh, K.; Schulbin, H.; Beard, A.; Cartee, L.; Liotta, D.C.; Schinazi, R.F.; Murphy, R.L. HIV DART 2002, Frontiers in Drug Development for Antiretroviral Therapies, Naples, Florida, USA, 15-19 December 2002. Antiviral Res. 2002, Abstracts, no 044.
53. Balzarini, J.; Pauwels, R.; Herdewijn, P.; De Clercq, E.; Cooney, D.A.; Kang, G.J.; Dalal, M.; Johns, D.G.; Broder, S. Biochem. Biophys. Res. Commun. 1986,140, 735-742.
54. Schinazi, R.F.; Mellors, J.; Bazmi, H.; Diamond, S.; Garber, S.; Gallagher, K.; Geleziunas, R.; Klabe, R.; Pierce, M.; Rayner, M.; Wu, J.T.; Zhang, H.; Hammond, J.; Bacheler, J.; Manion, D.J.; Otto, M.J.; Stuyver, L.; Trainor, G.; Liotta, D.C.; Erickson-Viitanen, S. Antimicrob. Agents Chemother. 2002, 46, 1394-1401.
55. Geleziunas, R.; Gallagher, K.; Zhang, H.; Bacheler, L.; Garber, S.; Wu, J.-T.; Shi, G.; Otto, M.J.; Schinazi, R.F.; Erickson-Viitanen, S. Antiviral Chem. Chemother. 2003, 14, 49-59.
56. Erickson-Viitanen, S.; Wu, J.-T.; Shi, G.; Unger, S.; King, R.W.; Fish, B.; Klabe, R.; Geleziunas, R.; Gallagher, K.; Otto, M.J.; Schinazi, R.F. Antiviral Chem. Chemother. 2003, 14, 39-47.
57. Murphy, R.L.; Schürmann, D.; Kravec, I.; Eron, J.; Havlir, D.; Beard, A.; Cartee, L.; Hurwitz, S.J.; Erickson-Viitanen, S.; Liotta, D.C.; Schinazi, R.F.; Otto, M.J. HIV DART 2002, Frontiers in Drug Development for Antiretroviral Therapies, Naples, Florida, USA, 15-19 December 2002. Antiviral Res. 2002, Abstracts, no 074.
58. Stoddart, C.A.; Bozeman, C.A.; Schinazi, R.F. HIV DART 2002, Frontiers in Drug Development for Antiretroviral Therapies, Naples, Florida, USA, 15-19 December 2002. Antiviral Res. 2002, Abstracts, no 023.
59. Furman, P.A.; Jeffrey, J.; Kiefer, L.L.; Feng, J.Y.; Anderson, K.S.; Borroto-Esoda, K.; Hill, E.; Copeland, W.C.; Chu, C.K.; Sommadossi, J.P.; Liberman, I.; Schinazi, R.F.; Painter, G.R. Antimicrob. Agents Chemother. 2001, 45, 158-165.
60. Jeffrey, J.L.; Feng, J.Y.; Qi, C.C.R.; Anderson, K.S.; Furman, P.A. J. Biol. Chem. 2003, 278, 18971-18979.
61. Kewn, S.; Wang, L.H.; Hoggard, P.O.; Rousseau, F.; Hart, R.; MacNeela, J.P.; Khoo, S.H.; Back, D.J. Antimicrob. Agents Chemother. 2003, 47, 255-261.
62. Painter, G.R.; St Claire, R.; Feng, J.; Borroto-Esoda, K. Fifteenth International Conference on Antiviral Research, Prague, Czech Republic, 17-21 March 2002. Antiviral Res. 2002, 53, A37, no 7.
63. Mewshaw, J.P.; Myrick, F.T.; Wakefield, D.A.C.S.; Hooper, B.J.; Harris, J.L.; McCreedy, B.; Borroto-Esoda, K. J. Acquir. Immune Defic. Syndr. 2002, 29, 11-20.
64. De Clereq, E. Expert Rev. Anti-infect. Ther. 2003, 1, 21-43.
65. Margot, N.A.; Isaacson, E.; McGowan, I.; Cheng, A.; Miller, M.D. J. Acquir. Immune Defic. Syndr. 2003, 33, 15-21.
66. Staszewski, S.; Gallant, J.; Pozniak, A.; Suleiman, J.M.A.H.; Dejesus, E.; Koenig, E.; Coleman, S.; Lu, B.; Cheng, A.K.; Coakley, D.F., XIV International AIDS Conference, Barcelona, Spain, 7-12 July 2002. Abstracts, no Or17.
67. th Conference on Retro viruses and Opportunistic Infections, Boston, MA, USA, 10-14 February 2003. Abstracts, no. 564b.
68. Van Rompay, K.K.A.; Schmidt, K.A.; Lawson, J.R.; Singh, R.; Bischofberger, N.; Marthas, M.L. J. Infect. Dis. 2002, 186, 1508-1513.
69. Louie, M.; Hogan, C.; Hurley, A.; Simon, V.; Chung, C.; Padte, N.; Lamy, P.; Flaherty, J.; Coakley, D.; Di Mascio, M.; Perelson, A.S.; Markowitz, M. AIDS 2003, 17, 1151-1156.
70. Nunez, M.; Pérez-Olmeda, M.; Diaz, B.; Rios, P.; Gonzalez-Lahoz, J.; Soriano, V. AIDS 2002, 16, 2352-2354.
71. Ristig, M.B.; Crippin, J.; Aberg, J.A.; Powderly, W.G.; Lisker-Melman, M.; Kessels, L.; Tebas, P. J. Infect. Dis. 2002, 186, 1844-1847.
72. Benhamou, Y.; Tubiana, R.; Thibault, V. N. Engl. J. Med. 2003, 348, 177-178.
73. Van Bommel, F.; Schernick, A.; Hopf, U.; Berg, T. Gastroenterology 2003, 124, 586-587.
74. th Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA, 10-14 February 2003. Abstracts, no. 824.
75. De Clercq, E. Antiviral Res. 1998, 38, 153-179.
76. Szczech, G.M.; Furman, P.; Painter, G.R.; Barry, D.W.; Borroto-Esoda, K.; Grizzle, T.B.; Blum, M.R.; Sommadossi, J.; Endoh, R.; Niwa, T.; Yamamoto, M.; Moxham, C. Antimicrob. Agents Chemother. 2000, 44, 123-130.
77. Borkow, G.; Barnard, J.; Nguyen, T.M.; Belmonte, A.; Wainberg, M.A.; Parniak, M.A. J. Virol. 1997, 71, 3023-3030.
78. Baizarini, J.; Naesens, L.; Verbeken, E.; Laga, M.; Van Damme, L.; Parniak, M.; Van Mellaert, L.; Anne, J.; De Clercq, E. AIDS 1998,12, 1129-1138.
79. Ren, J.; Nichols, C.; Bird, L.E.; Fujiwara, T.; Sugimoto, H.; Stuart, D.I.; Stammers, D.K. J. Biol. Chem. 2000, 275, 14316-14320.
80. Corbett, J.W.; Ko, S.S.; Rodgers, J.D.; Jeffrey, S.; Bacheler, L.T.; Klabe, R.M.; Diamond, S.; Lai, C.M.; Rabel, S.R.; Saye, J.A.; Adams, S.P.; Trainor, G.L.; Anderson, P.S.; Erickson-Viitanen, S.K. Antimicrob. Agents Chemother. 1999, 43, 2893-2897.
81. Corbett, J.W.; Ko, S.S.; Rodgers, J.D.; Gearhart, L.A.; Magnus, N.A.; Bacheler, L.T.; Diamond, S.; Jeffrey, S.; Klabe, R.M.; Cordova, B.C.; Garber, S.; Logue, K.; Trainor, G.L.; Anderson, P.S.; Erickson-Viitanen, S.K. J. Med. Chem. 2000,43, 2019-2030.
82. Ruiz, N.; Nusrat, R.; Lauenroth-Mai, E.; Berger, D.; Walworth, C.; Bacheler, L.T.; Ploughman, L.; Tsang, P.; Labriola, D.; Echols, R.; Levy, R.; the DPC 083-203 Study Team. 9th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, USA, 24-28 February 2002. Abstracts, p 55, no 6.
83. th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, USA, 24-28 February 2002. Abstracts, p. 55, no. 7.
84. th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 17-20 September 2000, no 1840.
85. Gazzard, B.; Pozniak, A.; Arasteh, K.; Staszewski, S.; Rozenbaum, W.; Yeni, P.; van 't Klooster, G.; De Dier, K.; Peelers, M.; de Béthune, M.-P.; Graham, N.; Pauwels, R. 9th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, USA, 24-28 February 2002. Abstracts, p 54, no 4.
86. Sankatsing, S.; Weverling, G.; van 't Klooster, G.; Prins, J.; Lange, J. 9th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, USA, 24-28 February 2002. Abstracts, p 54, no 5.
87. Dayam, R.; Neamati, N. Curr. Pharm. Design 2003, 9, 1789-1902.
88. King, P.J.; Robinson Jr., W.E. J. Virol. 1998, 72, 8420-8424.
89. King, P.J.; Lee, D.J.; Reinke, R.A.; Victoria, J.G.; Beale, K.; Robinson Jr., W.E. Virology 2003, 306, 147-161.
90. Pluymers, W.; Neamati, N.; Pannecouque, C.; Fikkert, V.; Marchand, C.; Burke Jr., T.R.; Pommier, Y.; Schols, D.; De Clercq, E.; Debyser, Z.; Witvrouw, M. Mol. Pharmacol. 2000, 58, 641-648.
91. Goldgur, Y.; Craigie, R.; Cohen, G.H.; Fujiwara, T.; Yoshinaga, T.; Fujishita, T.; Sugimoto, H.; Endo, T.; Murai, H.; Davies, D.R. Proc. Natl. Acad. Sci. USA 1999, 96, 13040-13043.
92. Hazuda, D.J.; Felock, P.; Witmer, M.; Wolfe, A.; Stillmock, K.; Grobler, J.A.; Espeseth, A.; Gabryelski, L.; Schleif, W.; Blau, C.; Miller, M.D. Science 2000, 287, 646-650.
93. Pluymers, W.; Pais, G.; Van Maele, B.; Pannecouque, C.; Fikkert, V.; Burke Jr., T.R.; De Clercq, E.; Witvrouw, M.; Neamati, N.; Debyser, Z. Antimicrob. Agents Chemother. 2002, 46, 3292-3297.
94. Fikkert, V.; Van Maele, B.; Vercammen, J.; Hantson, A.; Van Remoortel, B.; Michiels, M.; Gurnari, C.; Pannecouque, C.; De Maeyer, M.; Engelborghs, Y.; De Clercq, E.; Debyser, Z.; Witvrouw, M. J. Virol 2003, 77, 11459-11470.
95. Yoshinaga, T.; Sato, A.; Fujishita, T.; Fujiwara, T. 9th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, USA, 24-28 February 2002. Abstracts, p 55, no 8.
96. Grobler, J.A.; Stillmock, K.; Hu, B.; Witmer, M.; Felock, P.; Espeseth, A.S.; Wolfe, A.; Egbertson, M.; Bourgeois, M.; Melamed, J.; Wai, J.S.; Young, S.; Vacca, J.; Hazuda, D.J. Proc. Natl. Acad. Sci. USA 2002, 99, 6661-6666.
97. Marchand, C.; Johnson, A.A.; Karki, R.G.; Pais, G.C.G.; Zhang, X.; Cowansage, K., Patel, T.A.; Nicklaus, M.C.; Burke, Jr., T.R.; Pommier, Y. Mol. Pharmacol 2003, 64, 600-609.
98. Wai, J.S.; Egbertson, M.S.; Payne, L.S.; Fisher, T.E.; Embrey, M.W.; Tran, L.O.; Melamed, J.Y.; Langford, H.M.; Guare Jr., J.P.; Zhuang, L.; Grey, V.E.; Vacca, J.P.; Holloway, M.K.; Naylor-Olsen, A.M.; Hazuda, D.J.; Felock, P.J.; Wolfe, A.L.; Stillmock, K.A.; Schleif, W.A.; Gabryelski, L.J.; Young, S.D. J. Med. Chem. 2000, 43, 4923-4926.
99. Zhang, X.; Pais, G.C.G.; Svarovskaia, E.S.; Marchand, C.; Johnson, A.A.; Karki, R.G.; Nicklaus, M.C.; Pathak, V.K.; Pommier, Y.; Burke Jr., T.R. Azido-containing aryl β-diketo acid HIV-1 integrase inhibitors. Bioorg. Med. Chem. Lett. 2003, 13, 1215-1219.
100. Shaw-Reid, C.A.; Munshi, V.; Graham, P.; Wolfe, A.; Witmer, M.; Danzeisen, R.; Olsen, D.B.; Carroll, S.S.; Embrey, M.; Wai, J.S.; Miller, M.D.; Cole, J.L.; Hazuda, D.J. J. Biol. Chem. 2003, 278, 2777-2780.
101. Zhuang, L.; Wai, J.S.; Embrey, M.W.; Fisher, T.E.; Egbertson, M.S.; Payne, L.S.; Guare Jr., J.P.; Vacca, J.P.; Hazuda, D.J.; Felock, P.J.; Wolfe, A.L.; Stillmock, K.A.; Witmer, M.V.; Moyer, G.; Schleif, W.A.; Gabryelski, L.J.; Leonard, Y.M.; Lynch, Jr., J.J.; Michelson, S.R.; Young, S.D. J. Med. Chem. 2003, 46, 453-456.
102. Pannecouque, C.; Pluymers, W.; Van Maele, B.; Tetz, V.; Cherepanov, P.; De Clercq, E.; Witvrouw, M.; Debyser, Z. Curr. Biol. 2002, 12, 1169-1177.
103. Daelemans, D.; Vandamme, A.M.; De Clercq, E. Antiviral Chem. Chemother. 1999, 10, 1-14.
104. Okamoto, H.; Cujec, T.P.; Okamoto, M.; Peterlin, B.M.; Baba, M.; Okamoto, T. Virology 2000, 272, 402-408.
105. Turpin, J.A.; Buckheit Jr., R.W.; Derse, D.; Hollingshead, M.; Williamson, K.; Palamone, C.; Osterling, M.C.; Hill, S.A.; Graham, L.; Schaeffer, C.A.; Bu, M.; Huang, M.; Cholody, W.M.; Michejda, C.J.; Rice, W.G. Antimicrob. Agents Chemother. 1998, 42, 487-494.
106. Chao, S.H.; Fujinaga, K.; Manon, J.E.; Taube, R.; Sausville, E.A.; Senderowicz, A.M.; Peterlin, B.M.; Price, D.H. J. Biol. Chem. 2000, 275, 28345-28348.
107. Baba, M.; Okamoto, M.; Takeuchi, H. Antimicrob. Agents Chemother. 1999, 43, 2350-2355.
108. Hamy, F.; Felder, E.R.; Heizmann, G.; Lazdins, J.; Aboul-ela, F.; Varani, G.; Karn, J.; Klimkait, T. Proc. Natl. Acad. Sci. USA 1997, 94, 3548-3553.
109. Daelemans, D.; Schols, D.; Witvrouw, M.; Pannecouque, C.; Hatse, S.; van Dooren, S.; Hamy, F.; Klimkait, T.; De Clercq, E.; Vandamme, A.-M. Mol. Pharmacol. 2000, 57, 116-124.
110. Parolin, C.; Gatto, B.; Del Vecchio, C.; Pecere, T.; Tramontano, E.; Cecchetti, V.; Fravolini, A.; Masiero, S.; Palumubo, M.; Palu, G. Antimicrob. Agents Chemother. 2003, 47, 889-896.
111. Chiu, Y.L.; Ho, C.K.; Saha, N.; Schwer, B.; Shuman, S.; Rana, T.M. Mol. Cell 2002, 10, 585-597.
112. Daelemans, D.; Esté, J.A.; Witvrouw, M.; Pannecouque, C.; Jonckheere, H.; Aquaro, S.; Perno, C.F.; De Clercq, E.; Vandamme, A.-M. Mol. Pharmacol. 1997, 52, 1157-1163.
113. Daelemans, D.; Afonina, E.; Nilsson, J.; Werner, G.; Kjems, J.; De Clercq, E.; Pavlakis, G.N.; Vandamme, A.-M. Proc. Natl. Acad. Sci. USA 2002, 99, 14440-14445.
114. Lagoja, I.M.; Pannecouque, C.; Musumeci, L.; Froeyen, M.; Van Aerschot, A.; Balzarini, J.; Herdewijn, P.; De Clercq, E. Helv. Chim. Acta 2002, 85, 1883-1892.
115. Lagoja, I.M.; Pannecouque, C.; Van Aerschot, A.; Witvrouw, M.; Debyser, Z.; Balzarini, J.; Herdewijn, P.; De Clercq, E. J. Med. Chem. 2003, 46, 1546-1553.
116. Stevens, M.; Pannecouque, C.; De Clercq, E.; Balzarini, J. Antimicrob. Agents Chemother. 2003, 47, 2951-2957.
117. Stevens, M.; Pannecouque, C.; De Clercq, E.; Balzarini, J. Antimicrob. Agents Chemother. 2003, 47, 3109-3116.
118. Gong, Y.F.; Robinson, B.S.; Rose, R.E.; Deminie, C.; Spicer, T.P.; Stock, D.; Colonno, R.J.; Lin, P.F.. Antimicrob. Agents Chemother. 2000, 44, 2319-2326.
119. Colonno, R.J.; Thiry, A.; Limoli, K.; Parkin, N. Antimicrob. Agents Chemother. 2003, 47, 1324-1333.
120. Haas, D.W.; Zala, C.; Schrader, S.; Piliero, P.; Jaeger, H.; Nunes, D.; Thiry, A.; Schnittman, S.; Sension, M. AIDS 2003, 17, 1339-1349.
121. Sanne, I.; Piliero, P.; Squires, K.; Thiry, A.; Schnittman, S. J. Acquir. Immune Defic. Syndr. 2003, 32, 18-29.
122. nd IAS Conference on HIV and Pathogenesis, Paris, France, 14-17 July 2003. Abstracts.
123. Yoshimura, K.; Kato, R.; Kavlick, M.F.; Nguyen, A.; Maroun, V.; Maeda, K.; Hussain, K.A.; Ghosh, A.K.; Gulnik, S.V.; Erickson, J.W.; Mitsuya, H. J. Virol. 2002, 76, 1349-1358.
124. de Béthune, M.; Wigerinck, P.; Jonckheere, H.; Tahri, A.; Maes, L.; Pauwels, R.; Erickson, J. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, USA, 16-19 December 2001. Abstracts, F-1677.
125. Van Der Geest, R.; Van Der Sandt, I.; Gille, D.; Groen, K.; Tritsmans, L.; Stoffels, P. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, USA, 16-19 December 2001. Abstracts, 1-1934.
126. rd; R.R.; Dueweke, T.J.; Thaisrivongs, S.; Tarpley, W.G. Antimicrob. Agents Chemother. 1997, 41, 1058-1063.
127. Turner, S.R.; Strohbach, J.W.; Tommasi, R.A.; Aristoff, P.A.; Johnson, P.D.; Skulnick, H.I.; Dolak, L.A.; Seest, E.P.; Tomich, P.K.; Bohanon, M.J.; Horng, M.M.; Lynn, J.C.; Chong, K.T.; Hinshaw, R.R.; Watenpaugh, K.D.; Janakiraman, M.N.; Thaisrivongs, S. J. Med. Chem. 1998, 41, 3467-3476.
128. Larder, B.A.; Hertogs, K.; Bloor, S.; van den Eynde, C.H.; DeCian, W.; Wang, Y.; Freimuth, W.W.; Tarpley, G. AIDS 2000, 14, 1943-1948.
129. Rusconi, S.; La Seta Catamancio, S.; Citterio, P.; Kurtagic, S.; Violin, M.; Balotta, C.; Moroni, M., Galli, M.; d'Arminio-Monforte, A. Antimicrob. Agents Chemother. 2000, 44, 1328-1332.
130. th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, USA, 24-28 February 2002. Abstracts, no. 434-W.
131. th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, USA, 24-28 February 2002. Abstracts, p. 261, no. 562-T.